Perforin and granzymes: function, dysfunction and human pathology

A defining property of cytotoxic lymphocytes is their expression and regulated secretion of potent toxins, including the pore-forming protein perforin and serine protease granzymes. Until recently, mechanisms of pore formation and granzyme transfer into the target cell were poorly understood, but advances in structural and cellular biology have now begun to unravel how synergy between perforin and granzymes brings about target cell death. These and other advances are demonstrating the surprisingly broad pathophysiological roles of the perforin–granzyme pathway, and this has important implications for understanding immune homeostasis and for developing immunotherapies for cancer and other diseases. In particular, we are beginning to define and understand a range of human diseases that are associated with a failure to deliver active perforin to target cells. In this Review, we discuss the current understanding of the structural, cellular and clinical aspects of perforin and granzyme biology.

[1]  J. Trapani,et al.  Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma , 2000, The Journal of experimental medicine.

[2]  M. Simon,et al.  Perforin Is Essential for Control of Ectromelia Virus but Not Related Poxviruses in Mice , 1999, Journal of Virology.

[3]  A. Fischer,et al.  Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. , 2009, The Journal of clinical investigation.

[4]  M. Slijper,et al.  NK Cell Protease Granzyme M Targets α-Tubulin and Disorganizes the Microtubule Network1 , 2008, The Journal of Immunology.

[5]  R. Gottlieb,et al.  New Paradigm for Lymphocyte Granule-mediated Cytotoxicity , 1996, The Journal of Biological Chemistry.

[6]  R. Tothill,et al.  Heterozygosity for the common perforin mutation, p.A91V, impairs the cytotoxicity of primary natural killer cells from healthy individuals , 2015, Immunology and cell biology.

[7]  E. Gabazza,et al.  Granzyme B is a novel interleukin-18 converting enzyme. , 2010, Journal of dermatological science.

[8]  Chau‐Ching Liu,et al.  Isolation and characterization of a serine esterase from cytolytic T cell granules , 1986, Cell.

[9]  P. Henkart,et al.  Cytotoxic lymphocyte granzymes trigger a target cell internal disintegration pathway leading to cytolysis and DNA breakdown. , 1994, Journal of immunology.

[10]  J. Trapani,et al.  Proteases in lymphocyte killer function: redundancy, polymorphism and questions remaining , 2010, Biological chemistry.

[11]  J. Lieberman,et al.  Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis. , 2005, Immunity.

[12]  Mark J. Smyth,et al.  Perforin-mediated target-cell death and immune homeostasis , 2006, Nature Reviews Immunology.

[13]  T. Ganz,et al.  An antimicrobial activity of cytolytic T cells mediated by granulysin. , 1998, Science.

[14]  P. Henkart,et al.  Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-destruction after Degranulation , 2002, The Journal of experimental medicine.

[15]  J. Whisstock,et al.  The molecular basis for perforin oligomerization and transmembrane pore assembly. , 2009, Immunity.

[16]  S. Cullen,et al.  Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α. , 2011, Molecular cell.

[17]  D. Eisenberg,et al.  Granulysin crystal structure and a structure-derived lytic mechanism. , 2003, Journal of molecular biology.

[18]  J. Trapani,et al.  Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. , 2002, Immunity.

[19]  E. Podack,et al.  Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity , 1986, Cell.

[20]  J. Trapani,et al.  Selective Regulation of Apoptosis: the Cytotoxic Lymphocyte Serpin Proteinase Inhibitor 9 Protects against Granzyme B-Mediated Apoptosis without Perturbing the Fas Cell Death Pathway , 1998, Molecular and Cellular Biology.

[21]  R. Clementi,et al.  A proportion of patients with lymphoma may harbor mutations of the perforin gene. , 2004, Blood.

[22]  J. D. Young,et al.  Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[23]  N. Bovenschen,et al.  Granzyme M: behind enemy lines , 2014, Cell Death and Differentiation.

[24]  Craig W. Reynolds,et al.  Purification and properties of cytoplasmic granules from cytotoxic rat LGL tumors. , 1984, Journal of immunology.

[25]  Craig W. Reynolds,et al.  Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors , 1984, The Journal of experimental medicine.

[26]  M. Zvelebil,et al.  Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid‐binding C2 domain , 1997, The EMBO journal.

[27]  J. Trapani,et al.  Calcium-dependent Plasma Membrane Binding and Cell Lysis by Perforin Are Mediated through Its C2 Domain , 2005, Journal of Biological Chemistry.

[28]  K. Gevaert,et al.  Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis , 2013, Cell Death and Differentiation.

[29]  H. Adami,et al.  Cancer risk following organ transplantation: a nationwide cohort study in Sweden , 2003, British Journal of Cancer.

[30]  C. Ewen,et al.  Granzyme H induces cell death primarily via a Bcl-2-sensitive mitochondrial cell death pathway that does not require direct Bid activation. , 2013, Molecular immunology.

[31]  L. Notarangelo,et al.  A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. , 2005, Blood.

[32]  J. Trapani,et al.  Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function. , 2007, Blood.

[33]  E. Remmerswaal,et al.  Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication , 2012, Cell Death and Differentiation.

[34]  J. Goedert,et al.  Association of cancer with AIDS-related immunosuppression in adults. , 2001, JAMA.

[35]  G. Janka,et al.  Familial and acquired hemophagocytic lymphohistiocytosis. , 2012, Annual review of medicine.

[36]  W. Rosenau,et al.  Lysis of homologous cells by sensitized lymphocytes in tissue culture. , 1961, Journal of the National Cancer Institute.

[37]  V. Engelhard,et al.  Reorientation and fusion of cytotoxic T lymphocyte granules after interaction with target cells as determined by high resolution cinemicrography. , 1986, Journal of immunology.

[38]  J. Rossjohn,et al.  The Mechanism of Membrane Insertion for a Cholesterol-Dependent Cytolysin A Novel Paradigm for Pore-Forming Toxins , 1999, Cell.

[39]  Helen R Saibil,et al.  Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. , 2013, Blood.

[40]  R. Gilbert,et al.  Perforin oligomers form arcs in cellular membranes: a locus for intracellular delivery of granzymes , 2014, Cell Death and Differentiation.

[41]  Olivia Susanto,et al.  Protection from endogenous perforin: glycans and the C terminus regulate exocytic trafficking in cytotoxic lymphocytes. , 2011, Immunity.

[42]  A. Fischer,et al.  Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis , 2002, British journal of haematology.

[43]  P. Saftig,et al.  Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage. , 2013, Blood.

[44]  A. F. Bykovsky,et al.  Ultrastructural alteration of cytolytic T lymphocytes following their interaction with target cells. II. Morphogenesis of secretory granules and intracellular vacuoles. , 1978, Cellular immunology.

[45]  A. Fischer,et al.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis. , 1999, Science.

[46]  A. Rosen,et al.  Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition , 2007, The EMBO journal.

[47]  S. Fuller,et al.  Centrosome polarization delivers secretory granules to the immunological synapse , 2006, Nature.

[48]  A. Fischer,et al.  Munc13-4 Is Essential for Cytolytic Granules Fusion and Is Mutated in a Form of Familial Hemophagocytic Lymphohistiocytosis (FHL3) , 2003, Cell.

[49]  S. E. Stewart,et al.  Mouse granzyme A induces a novel death with writhing morphology that is mechanistically distinct from granzyme B-induced apoptosis , 2013, Cell Death and Differentiation.

[50]  J. Tschopp,et al.  A family of serine esterases in lytic granules of cytolytic T lymphocytes , 1987, Cell.

[51]  J. Trapani,et al.  Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors. , 2003, Immunity.

[52]  E. Paz-Artal,et al.  Familial hemophagocytic lymphohistiocytosis in an adult patient homozygous for A91V in the perforin gene, with tuberculosis infection. , 2006, Haematologica.

[53]  K. Baetz,et al.  Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re‐filling of the lytic granules and secretion of lytic proteins via a non‐granule pathway , 1995, European journal of immunology.

[54]  Alex T. Ritter,et al.  The role of the cytoskeleton at the immunological synapse , 2013, Immunological reviews.

[55]  J. Whisstock,et al.  The structural basis for membrane binding and pore formation by lymphocyte perforin , 2010, Nature.

[56]  N. Thornberry,et al.  Mouse and Human Granzyme B Have Distinct Tetrapeptide Specificities and Abilities to Recruit the Bid Pathway* , 2007, Journal of Biological Chemistry.

[57]  J. Trapani,et al.  A functional genomics screen identifies PCAF and ADA3 as regulators of human granzyme B-mediated apoptosis and Bid cleavage , 2014, Cell Death and Differentiation.

[58]  J. Whisstock,et al.  Protecting a serial killer: pathways for perforin trafficking and self-defence ensure sequential target cell death. , 2012, Trends in immunology.

[59]  P. Greenberg,et al.  MicroRNA-150 regulates the cytotoxicity of natural killers by targeting perforin-1. , 2014, The Journal of allergy and clinical immunology.

[60]  J. Trapani,et al.  Perforinopathy: A Spectrum of Human Immune Disease Caused by Defective Perforin Delivery or Function , 2013, Front. Immunol..

[61]  S. Ehl,et al.  Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. , 2009, American journal of human genetics.

[62]  真貝 洋一 Homology of perforin to the ninth component of complement (C9) , 1990 .

[63]  S. Akira,et al.  A Role for Granzyme M in TLR4-Driven Inflammation and Endotoxicosis , 2010, The Journal of Immunology.

[64]  M. Aricò,et al.  A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia? , 2005, Haematologica.

[65]  Yuan-Tsong Chen,et al.  Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis , 2008, Nature Medicine.

[66]  P. Greenberg,et al.  Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity. , 2011, Blood.

[67]  C. Peters,et al.  Cytotoxic T Lymphocytes from Cathepsin B-deficient Mice Survive Normally in Vitro and in Vivo after Encountering and Killing Target Cells* , 2006, Journal of Biological Chemistry.

[68]  M. Simon,et al.  Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[69]  D. Green,et al.  Granzyme B–Mediated Cytochrome C Release Is Regulated by the Bcl-2 Family Members Bid and Bax , 2000, The Journal of experimental medicine.

[70]  J. Trapani,et al.  Apoptosis induced by the lymphocyte effector molecule perforin. , 2007, Current opinion in immunology.

[71]  A. Rao,et al.  MicroRNA-directed program of cytotoxic CD8+ T-cell differentiation , 2013, Proceedings of the National Academy of Sciences.

[72]  Alexandre F. Carisey,et al.  The central role of the cytoskeleton in mechanisms and functions of the NK cell immune synapse , 2013, Immunological reviews.

[73]  F. Andrade Non‐cytotoxic antiviral activities of granzymes in the context of the immune antiviral state , 2010, Immunological reviews.

[74]  E. Gabazza,et al.  CD8+ T cell granzyme B activates keratinocyte endogenous IL-18 , 2014, Archives of Dermatological Research.

[75]  J. Trapani,et al.  Human perforin mutations and susceptibility to multiple primary cancers , 2013, Oncoimmunology.

[76]  A. Anel,et al.  A case of partial dedicator of cytokinesis 8 deficiency with altered effector phenotype and impaired CD8⁺ and natural killer cell cytotoxicity. , 2014, The Journal of allergy and clinical immunology.

[77]  Maya Topf,et al.  Stepwise visualization of membrane pore formation by suilysin, a bacterial cholesterol-dependent cytolysin , 2014, eLife.

[78]  J. Trapani,et al.  Granzyme M Mediates a Novel Form of Perforin-dependent Cell Death* , 2004, Journal of Biological Chemistry.

[79]  J. Trapani,et al.  Discordant Regulation of Granzyme H and Granzyme B Expression in Human Lymphocytes* , 2004, Journal of Biological Chemistry.

[80]  T. Ley,et al.  Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Q. Mei,et al.  Rapid reuptake of granzyme B leads to emperitosis: an apoptotic cell-in-cell death of immune killer cells inside tumor cells , 2013, Cell Death and Disease.

[82]  G. Anderluh,et al.  Human perforin permeabilizing activity, but not binding to lipid membranes, is affected by pH. , 2010, Molecular immunology.

[83]  J. Shiver,et al.  Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A , 1992, Cell.

[84]  M. Aricò,et al.  Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphoma , 2007, Cancer.

[85]  S. Singer,et al.  On the mechanism of unidirectional killing in mixtures of two cytotoxic T lymphocytes. Unidirectional polarization of cytoplasmic organelles and the membrane-associated cytoskeleton in the effector cell , 1986, The Journal of experimental medicine.

[86]  J. D. Young,et al.  Dissociation of membrane binding and lytic activities of the lymphocyte pore-forming protein (perforin) , 1987, The Journal of experimental medicine.

[87]  J. Whisstock,et al.  Perforin: structure, function, and role in human immunopathology , 2010, Immunological reviews.

[88]  P. Mcneil,et al.  Plasma membrane disruption: repair, prevention, adaptation. , 2003, Annual review of cell and developmental biology.

[89]  A. Fischer,et al.  Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules , 2010, Nature Reviews Immunology.

[90]  William E. Balch,et al.  An Adaptable Standard for Protein Export from the Endoplasmic Reticulum , 2007, Cell.

[91]  R. Gilbert Inactivation and activity of cholesterol-dependent cytolysins: what structural studies tell us. , 2005, Structure.

[92]  Alex Bateman,et al.  MEROPS: the database of proteolytic enzymes, their substrates and inhibitors , 2011, Nucleic Acids Res..

[93]  James C. Whisstock,et al.  Bioinformatics Discovery Note Structural Bioinformatics Predicting Giant Transmembrane Β-barrel Architecture , 2022 .

[94]  W. Al-Herz,et al.  Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2. , 2010, Blood.

[95]  D. Granville,et al.  Granzyme B in injury, inflammation, and repair. , 2012, Trends in molecular medicine.

[96]  F. Q. Ribeiro The meta-analysis , 2017, Brazilian journal of otorhinolaryngology.

[97]  Helen R. Saibil,et al.  Structural Basis of Pore Formation by the Bacterial Toxin Pneumolysin , 2005, Cell.

[98]  R. Gatti,et al.  Occurrence of malignancy in immunodeficiency diseases: A literature review , 1971, Cancer.

[99]  Michael J. Byrne,et al.  Wiskott–Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[100]  Li Lin,et al.  Identification of Resting and Type I IFN-Activated Human NK Cell miRNomes Reveals MicroRNA-378 and MicroRNA-30e as Negative Regulators of NK Cell Cytotoxicity , 2012, The Journal of Immunology.

[101]  H. Macdonald,et al.  Granzyme A is an interleukin 1 beta-converting enzyme , 1995, The Journal of experimental medicine.

[102]  T. van der Poll,et al.  Granzyme K synergistically potentiates LPS-induced cytokine responses in human monocytes , 2014, Proceedings of the National Academy of Sciences.

[103]  D. Granville,et al.  Granzyme B degrades extracellular matrix and contributes to delayed wound closure in apolipoprotein E knockout mice , 2013, Cell Death and Differentiation.

[104]  Ashley M Buckle,et al.  A Common Fold Mediates Vertebrate Defense and Bacterial Attack , 2007, Science.

[105]  Neil D. Rawlings,et al.  MEROPS: the database of proteolytic enzymes, their substrates and inhibitors , 2013, Nucleic Acids Res..

[106]  A. Krensky,et al.  Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. , 1997, Journal of immunology.

[107]  A. Oner,et al.  Clinical and molecular aspects of Turkish familial hemophagocytic lymphohistiocytosis patients with perforin mutations. , 2008, Leukemia research.

[108]  R. Aebersold,et al.  Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions , 1992, The Journal of experimental medicine.

[109]  J. Coligan,et al.  LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity. , 2013, Blood.

[110]  J. Wolchok,et al.  Immune Checkpoint Blockade , 2019, Methods in Molecular Biology.

[111]  Deqing Hu,et al.  Cleavage of Survivin by Granzyme M Triggers Degradation of the Survivin-X-linked Inhibitor of Apoptosis Protein (XIAP) Complex to Free Caspase Activity Leading to Cytolysis of Target Tumor Cells* , 2010, Journal of Biological Chemistry.

[112]  N. Bovenschen,et al.  All Human Granzymes Target hnRNP K That Is Essential for Tumor Cell Viability* , 2012, The Journal of Biological Chemistry.

[113]  E. Mejstrikova,et al.  Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). , 2012, Blood.

[114]  J. Allison,et al.  Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.

[115]  L. Moretta,et al.  Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. , 2006, Blood.

[116]  C. Peters,et al.  Cathepsin H Is an Additional Convertase of Pro-granzyme B , 2010, The Journal of Biological Chemistry.

[117]  J. Lieberman,et al.  Perforin pores in the endosomal membrane trigger release of endocytosed granzyme B to the cytosol of target cells , 2011, Nature Immunology.

[118]  J. Trapani,et al.  Initiation of Apoptosis by Granzyme B Requires Direct Cleavage of Bid, but Not Direct Granzyme B–Mediated Caspase Activation , 2000, The Journal of experimental medicine.

[119]  J. Lieberman,et al.  Cytotoxic Cells Kill Intracellular Bacteria through Granulysin-Mediated Delivery of Granzymes , 2014, Cell.

[120]  M. Aricò,et al.  Genotype–phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations , 2007, Journal of Medical Genetics.

[121]  James C. Whisstock,et al.  The major human and mouse granzymes are structurally and functionally divergent , 2006, The Journal of cell biology.

[122]  Anjana Rao,et al.  The transcriptional control of the perforin locus , 2010, Immunological reviews.

[123]  R. Aebersold,et al.  A natural killer cell granule protein that induces DNA fragmentation and apoptosis , 1992, The Journal of experimental medicine.

[124]  J. Trapani,et al.  A Natural Genetic Variant of Granzyme B Confers Lethality to a Common Viral Infection , 2014, PLoS pathogens.

[125]  O. Gerasimenko,et al.  Calcium uptake via endocytosis with rapid release from acidifying endosomes , 1998, Current Biology.

[126]  R. Zinkernagel,et al.  Decreased tumor surveillance in perforin-deficient mice , 1996, The Journal of experimental medicine.

[127]  A. Rao,et al.  Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs , 2009, The Journal of experimental medicine.

[128]  J. D. Young,et al.  The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities. , 1986, Science.

[129]  Lianfa Shi,et al.  Human and mouse granzyme A induce a proinflammatory cytokine response. , 2008, Immunity.

[130]  D. Vaux,et al.  Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes. , 1997, Journal of immunology.

[131]  J. Lieberman,et al.  Perforin activates clathrin- and dynamin-dependent endocytosis, which is required for plasma membrane repair and delivery of granzyme B for granzyme-mediated apoptosis. , 2010, Blood.

[132]  M. Bevan,et al.  Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. , 2010, Immunity.

[133]  J. Trapani,et al.  Killing by cytotoxic T cells and natural killer cells: Multiple granule serine proteases as initiators of DNA fragmentation , 1993, Immunology and cell biology.

[134]  J. Casanova,et al.  DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice , 2011, The Journal of experimental medicine.

[135]  Chun Xing Li,et al.  Granzyme K inhibits replication of influenza virus through cleaving the nuclear transport complex importin α1/β dimer of infected host cells , 2011, Cell Death and Differentiation.

[136]  J. Trapani,et al.  Perforin deficiency and susceptibility to cancer , 2010, Cell Death and Differentiation.

[137]  A. F. Bykovsky,et al.  Ultrastructural alteration of cytolytic T lymphocytes following their interaction with target cells. I. Hypertrophy and change of orientation of the Golgi apparatus. , 1978, Cellular immunology.

[138]  R. Clementi,et al.  Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. , 2002, Blood.

[139]  C. Buckley Behind enemy lines. , 1996, Tobacco control.

[140]  J. Trapani,et al.  Rapid and Unidirectional Perforin Pore Delivery at the Cytotoxic Immune Synapse , 2013, The Journal of Immunology.

[141]  J. Haefliger,et al.  Identification and sequencing of cDNA clones encoding the granule-associated serine proteases granzymes D, E, and F of cytolytic T lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[142]  Timothy J. Ley,et al.  Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells , 1994, Cell.

[143]  J. Wolchok,et al.  Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy , 2014, Science Translational Medicine.

[144]  S. Cullen,et al.  Human and murine granzyme B exhibit divergent substrate preferences , 2007, The Journal of Cell Biology.

[145]  G. Griffiths,et al.  Granzymes A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor , 1993, The Journal of cell biology.

[146]  P. Xia,et al.  FADD cleavage by NK cell granzyme M enhances its self-association to facilitate procaspase-8 recruitment for auto-processing leading to caspase cascade , 2011, Cell Death and Differentiation.

[147]  A. Anel,et al.  The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte‐mediated apoptosis is determined by the quality of target cells , 2002, European journal of immunology.

[148]  N. Sonenberg,et al.  Granzyme B Inhibits Vaccinia Virus Production through Proteolytic Cleavage of Eukaryotic Initiation Factor 4 Gamma 3 , 2011, PLoS pathogens.

[149]  E. M. Renkin,et al.  FILTRATION, DIFFUSION, AND MOLECULAR SIEVING THROUGH POROUS CELLULOSE MEMBRANES , 1954, The Journal of general physiology.

[150]  J. Whisstock,et al.  Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer , 2009, Proceedings of the National Academy of Sciences.

[151]  C. Froelich,et al.  Human granzyme B is essential for DNA fragmentation of susceptible target cells , 1994, European journal of immunology.

[152]  J. Slot,et al.  Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes , 1991, The Journal of experimental medicine.

[153]  J. Kelly,et al.  The Biological and Chemical Basis for Tissue-Selective Amyloid Disease , 2005, Cell.

[154]  M. Devidas,et al.  Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group , 2006, Leukemia.

[155]  S. Spijkers,et al.  Elevated granzyme M-expressing lymphocytes during cytomegalovirus latency and reactivation after allogeneic stem cell transplantation. , 2014, Clinical immunology.

[156]  A. Lanzavecchia,et al.  Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes. , 1988, Journal of immunology.

[157]  Z. Fan,et al.  Granzyme M Directly Cleaves Inhibitor of Caspase-Activated DNase (CAD) to Unleash CAD Leading to DNA Fragmentation1 , 2006, The Journal of Immunology.

[158]  Philip G Ashton-Rickardt,et al.  Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules. , 2006, Immunity.

[159]  L. Dupré,et al.  An initial and rapid step of lytic granule secretion precedes microtubule organizing center polarization at the cytotoxic T lymphocyte/target cell synapse , 2013, Proceedings of the National Academy of Sciences.

[160]  Lukasz,et al.  Crystal Structure of the MACPF Domain of Human Complement Protein C 8 α in Complex with the C 8 γ Subunit , 2008 .

[161]  J. Trapani,et al.  Granzyme B (GraB) Autonomously Crosses the Cell Membrane and Perforin Initiates Apoptosis and GraB Nuclear Localization , 1997, The Journal of experimental medicine.

[162]  G. Anderluh,et al.  Membrane pore formation at protein-lipid interfaces. , 2014, Trends in biochemical sciences.

[163]  Ammar Husami,et al.  Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. , 2014, Blood.

[164]  P. Henkart,et al.  Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin , 1995, The Journal of experimental medicine.

[165]  A. Rao,et al.  Chromosome transfer activates and delineates a locus control region for perforin. , 2007, Immunity.

[166]  James C. Whisstock,et al.  A New Model for Pore Formation by Cholesterol-Dependent Cytolysins , 2014, PLoS Comput. Biol..

[167]  G. Anderluh,et al.  Perforin Rapidly Induces Plasma Membrane Phospholipid Flip-Flop , 2011, PloS one.

[168]  T. Ley,et al.  Papillon-Lefèvre Syndrome: Correlating the Molecular, Cellular, and Clinical Consequences of Cathepsin C/Dipeptidyl Peptidase I Deficiency in Humans1 , 2004, The Journal of Immunology.

[169]  R. Clementi,et al.  Atypical features of familial hemophagocytic lymphohistiocytosis. , 2004, Blood.

[170]  M. Smyth,et al.  Functional Analysis of Granzyme M and Its Role in Immunity to Infection1 , 2005, The Journal of Immunology.

[171]  A. Filipovich,et al.  Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. , 2005, The Journal of clinical investigation.

[172]  Piet Gros,et al.  Structure of C8α-MACPF Reveals Mechanism of Membrane Attack in Complement Immune Defense , 2007, Science.

[173]  J. Trapani,et al.  A Critical Role for Granzymes in Antigen Cross-Presentation through Regulating Phagocytosis of Killed Tumor Cells , 2011, The Journal of Immunology.

[174]  J. Trapani,et al.  Granzyme B triggers a prolonged pressure to die in Bcl-2 overexpressing cells, defining a window of opportunity for effective treatment with ABT-737 , 2012, Cell Death and Disease.

[175]  B. Gustafsson,et al.  Development of classical Hodgkin’s lymphoma in an adult with biallelic STXBP2 mutations , 2013, Haematologica.

[176]  T. Schall,et al.  The isolation and sequence of a novel gene from a human functional T cell line , 1987, The Journal of experimental medicine.

[177]  E. Jaffe,et al.  Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. , 2004, Blood.

[178]  B. Thiers Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis , 2008 .

[179]  R. Zinkernagel,et al.  Perforin dependence of natural killer cell‐mediated tumor control in vivo , 1995, European journal of immunology.

[180]  J. Zimmer,et al.  Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia , 2013, Proceedings of the National Academy of Sciences.

[181]  C. Simone,et al.  Electron microscopic demonstration of lesions in target cell membranes associated with antibody-dependent cellular cytotoxicity. , 1980, Clinical and experimental immunology.

[182]  Eric O Long,et al.  Cytotoxic immunological synapses , 2010, Immunological reviews.

[183]  P. Bird,et al.  Blessing or curse? Proteomics in granzyme research , 2014, Proteomics. Clinical applications.

[184]  A. Alcaraz,et al.  Elucidating sources and roles of granzymes A and B during bacterial infection and sepsis. , 2014, Cell reports.

[185]  J. Trapani,et al.  Cytosolic Delivery of Granzyme B by Bacterial Toxins: Evidence that Endosomal Disruption, in Addition to Transmembrane Pore Formation, Is an Important Function of Perforin , 1999, Molecular and Cellular Biology.

[186]  J. Trapani,et al.  The granzyme B gene is highly polymorphic in wild mice but essentially invariant in common inbred laboratory strains. , 2007, Tissue antigens.

[187]  J. Trapani,et al.  Granzyme K expressing cytotoxic T lymphocytes protects against influenza virus in granzyme AB-/- mice. , 2008, Viral immunology.

[188]  E. Caler,et al.  Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes , 2001, Cell.

[189]  J. Trapani,et al.  Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time , 2015, The Journal of experimental medicine.

[190]  H. Hennies,et al.  Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. , 2005, Human molecular genetics.